Ipratropium bromide/Salbutamol Neutec 0.5/2.5 mg per 2.5 ml nebuliser solution আয়ার্লণ্ড - ইংরেজি - HPRA (Health Products Regulatory Authority)

ipratropium bromide/salbutamol neutec 0.5/2.5 mg per 2.5 ml nebuliser solution

neutec inhaler ireland limited - ipratropium bromide monohydrate; salbutamol sulfate - nebuliser solution - salbutamol and ipratropium bromide

TEVA-SALBUTAMOL HFA METERED-DOSE AEROSOL কানাডা - ইংরেজি - Health Canada

teva-salbutamol hfa metered-dose aerosol

teva canada limited - salbutamol (salbutamol sulfate) - metered-dose aerosol - 100mcg - salbutamol (salbutamol sulfate) 100mcg - selective beta 2-adrenergic agonists

SANDOZ SALBUTAMOL SOLUTION কানাডা - ইংরেজি - Health Canada

sandoz salbutamol solution

sandoz canada incorporated - salbutamol (salbutamol sulfate) - solution - 5mg - salbutamol (salbutamol sulfate) 5mg - selective beta 2-adrenergic agonists

Salbutamol K-haler নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

salbutamol k-haler

viatris limited - salbutamol sulfate 120ug equivalent to salbutamol 100 µg;   - aerosol inhaler, metered dose - 100 mcg - active: salbutamol sulfate 120ug equivalent to salbutamol 100 µg   excipient: ethanol norflurane oleic acid

SalAir নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

salair

rex medical ltd - salbutamol sulfate 0.12mg equivalent to 100 mcg salbutamol - aerosol inhaler, metered dose - 100 mcg/dose - active: salbutamol sulfate 0.12mg equivalent to 100 mcg salbutamol excipient: ethanol norflurane oleic acid - salbutamol sulphate is indicated for the prevention and treatment of bronchospasm and acts on the ?2 (beta-2) adrenoceptors of bronchial muscle at therapeutic doses, with little or no action on the ?1 (beta-1) adrenoceptors of the heart. with its fast onset of action, it is particularly suitable for the management and prevention of attack in mild asthma and for the treatment of acute exacerbations in moderate to severe asthma. patients with unstable or severe asthma should not rely on bronchodilators as the main or only form of treatment. severe asthma requires regular medical assessment as death may occur. patients with severe asthma have constant symptoms and frequent exacerbations, with limited physical capacity, and pef values below 60% (predicted at baseline) with greater than 30% variability, usually not returning entirely to normal after a bronchodiliator. together with corticosteroid treatment, salair inhaler provides essential rescue medication for severe asthmatics in treating acute exace

Salbutamol নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

salbutamol

origen pharmaceuticals limited - salbutamol sulfate 0.4 mg/ml - elixir - 2mg/5ml - active: salbutamol sulfate 0.4 mg/ml

Salbutamol নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

salbutamol

origen pharmaceuticals limited - salbutamol sulfate 1 mg/ml - solution for infusion - 5mg/5ml - active: salbutamol sulfate 1 mg/ml

Salbutamol নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

salbutamol

origen pharmaceuticals limited - salbutamol sulfate 0.5 mg/ml - solution for injection - 0.5 mg/ml - active: salbutamol sulfate 0.5 mg/ml

Salbutamol Respirator Solution নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

salbutamol respirator solution

origen pharmaceuticals limited - salbutamol sulfate 0.4 mg/ml - solution for inhalation - 2mg/5ml - active: salbutamol sulfate 0.4 mg/ml